Healthcare/Biotech
Matrix Prasad's Iquest Enterprises buys Viatris India API business
Nimmagadda Prasad, known as 'Matrix Prasad,' is an accused in the corruption cases being probed against Andhra Pradesh Chief Minister Jagan Mohan Reddy by Enforcement Directorate (ED) and the Central Bureau of Investigation (CBI), related to the Vadarevu-Nizampatnam Port and Industrial Corridor (Vanpic) project.
- How AI is changing the pharmaceutical industry in India
- Pharma cos can supply generic Bedaquiline to other countries
- AstraZeneca gets CDSCO approval for preventive therapy for respiratory syncytial virus
- Investment of Rs 6k cr approved by Centre under PLI scheme for pharma, medical devices sectors: Amit Shah
- PE Advent completes acquisition of Suven Pharma, appoints new Board and management team
- Novo Nordisk India head eyes 2026 launch for obesity drug Wegovy, warns against copycats
- Dengue causing blood pressure, heart rate changes
- WHO South-East Asia Region calls on member states to raise awareness about heart health
- Norwest set to buy 40% in Regency Health for '600 cr
- 'Most small drug companies unnerved by GMP compliance norm'
- About 70 per cent of premature cancer deaths in 2020 preventable, 30 per cent treatable: Lancet study
- Apollo acquires under-development hospital asset from Future Oncology in Kolkata for Rs 102 crore
- 'Most small drug companies unnerved by GMP compliance norm'
- About 70 per cent of premature cancer deaths in 2020 preventable, 30 per cent treatable: Lancet study
- Apollo acquires under-development hospital asset from Future Oncology in Kolkata for Rs 102 crore
- CVC may sell controlling stake in Indian hospital chain HealthCare Global
- Government unveils National Policy on R&D in pharma, medtech
- Clinical trials of new drugs over-recruiting Indians: Study
Biotech
- Biocon appoints Peter Bains as Group CEO
- On track to integrate major part of Viatris'' acquired biosimilars biz this fiscal: Kiran Mazumdar-Shaw
- Competition Commission of India clears Kotak-Biocon Biologics deal
- Biocon Biologics announces top leadership appointments
- Biocon Biologics gets eight observations from USFDA for Malaysia insulin facility
Healthcare
- Novo Nordisk India head eyes 2026 launch for obesity drug Wegovy, warns against copycats
- Dengue causing blood pressure, heart rate changes
- WHO South-East Asia Region calls on member states to raise awareness about heart health
- Norwest set to buy 40% in Regency Health for '600 cr
- About 70 per cent of premature cancer deaths in 2020 preventable, 30 per cent treatable: Lancet study
Pharmaceuticals
Matrix Prasad's Iquest Enterprises buys Viatris India API business
Pharma cos can supply generic Bedaquiline to other countries
AstraZeneca gets CDSCO approval for preventive therapy for respiratory syncytial virus
PE Advent completes acquisition of Suven Pharma, appoints new Board and management team
Government unveils National Policy on R&D in pharma, medtech
Must Watch
BACK TO TOP